Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Virol
    November 2021
  1. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    >> Share

  2. DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
    Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
    J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
    >> Share

  3. CHAI H, Li X, Li M, Lv X, et al
    Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
    J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
    >> Share

  4. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    >> Share

  5. DONG X, Wang X, Xie M, Wu W, et al
    Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
    J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
    >> Share

    October 2021
  6. TAN J, O'Dell G, Hernandez MM, Sordillo EM, et al
    Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model.
    J Virol. 2021 Oct 20:JVI0142121. doi: 10.1128/JVI.01421.
    >> Share

  7. GAO Q, Yang C, Ren C, Zhang S, et al
    Correction for Gao et al., "Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus".
    J Virol. 2021;95:e0141321.
    >> Share

  8. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    >> Share

  9. BESSIERE P, Figueroa T, Coggon A, Foret-Lucas C, et al
    Opposite outcomes of the within-host competition between highly and low pathogenic H5N8 avian influenza viruses in chickens compared to ducks.
    J Virol. 2021 Oct 6:JVI0136621. doi: 10.1128/JVI.01366.
    >> Share

    September 2021
  10. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  11. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    >> Share

  12. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    >> Share

  13. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  14. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    >> Share

  15. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  16. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    >> Share

  17. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    >> Share

  18. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    >> Share

  19. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    >> Share

    August 2021
  20. XUN G, Song X, Hu J, Zhang H, et al
    Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    J Virol. 2021;95:e0048521.
    >> Share

  21. SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
    TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
    J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
    >> Share

  22. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    >> Share

  23. KAPLAN BS, Anderson TK, Chang J, Santos J, et al
    Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
    J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
    >> Share

  24. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    >> Share

  25. TAM EH, Liu YC, Woung CH, Liu HM, et al
    Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
    J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
    >> Share

  26. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

    July 2021
  27. DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
    Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
    J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
    >> Share

  28. BESTLE D, Limburg H, Kruhl D, Harbig A, et al
    Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
    J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
    >> Share

  29. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    >> Share

  30. GREEN G, Johnson SM, Costello H, Brakel K, et al
    CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    J Virol. 2021;95:e0001021.
    >> Share

  31. YANG J, Zhang P, Huang M, Qiao S, et al
    Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
    J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
    >> Share

  32. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    >> Share

  33. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    >> Share

  34. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    >> Share

  35. LAI KK, Cheung NN, Yang F, Dai J, et al
    Correction for Lai et al., "Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics".
    J Virol. 2021;95:e0066521.
    >> Share

  36. LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
    Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
    J Virol. 2021;95:e0056321.
    >> Share

  37. LEYSON CM, Youk S, Ferreira HL, Suarez DL, et al
    Multiple gene segments are associated with enhanced virulence of clade 2.3.4.4 H5N8 highly pathogenic avian influenza virus in mallards.
    J Virol. 2021 Jul 7:JVI0095521. doi: 10.1128/JVI.00955.
    >> Share

    June 2021
  38. YU J, Huang C, Sheng Z, Wang Z, et al
    Identification of One Critical Amino Acid Residue of the Nucleoprotein as a Determinant for in vitro Viral Replication Fitness of Influenza D Virus.
    J Virol. 2021 Jun 30:JVI0097121. doi: 10.1128/JVI.00971.
    >> Share

  39. XIAO Y, Zhang W, Pan M, Bauer DLV, et al
    A synergistic effect between 3' terminal noncoding and adjacent coding regions of influenza A virus HA segment on template preference.
    J Virol. 2021 Jun 30:JVI0087821. doi: 10.1128/JVI.00878.
    >> Share

  40. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    >> Share

  41. BLAUROCK C, Breithaupt A, Scheibner D, Bagato O, et al
    Preferential selection and contribution of non-structural protein 1 (NS1) to the efficient transmission of the panzootic avian influenza H5N8 2.3.4.4 clades A and B viruses in chickens and ducks.
    J Virol. 2021 Jun 23:JVI0044521. doi: 10.1128/JVI.00445.
    >> Share

  42. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    >> Share

  43. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    >> Share

  44. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    >> Share

  45. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    >> Share

  46. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    >> Share

  47. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share

    May 2021
  48. LIU H, Plancarte M, Ball EE, Weiss CM, et al
    Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques.
    J Virol. 2021 May 26:JVI0040321. doi: 10.1128/JVI.00403.
    >> Share

  49. BAKRE A, Jones L, Murray J, Reneer ZB, et al
    Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
    J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
    >> Share

  50. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    >> Share

  51. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    >> Share

  52. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    >> Share

  53. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

  54. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    >> Share

    April 2021
  55. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    >> Share

  56. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    >> Share

  57. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    >> Share

  58. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    >> Share

  59. CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
    Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
    J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
    >> Share

  60. NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
    Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
    J Virol. 2021;95.
    >> Share

  61. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    >> Share

  62. ZHENG J, Wen L, Yen HL, Liu M, et al
    Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
    J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
    >> Share

  63. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    >> Share

  64. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  65. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    >> Share

  66. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    >> Share

  67. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    >> Share

  68. SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
    Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
    J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
    >> Share

  69. DANZY S, Lowen AC, Steel J
    A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
    J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
    >> Share

  70. PU J, Yin Y, Liu J, Wang X, et al
    Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
    J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
    >> Share

  71. YANG H, Winkler W, Wu X
    Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.
    J Virol. 2021 Mar 10. pii: JVI.00283-21. doi: 10.1128/JVI.00283.
    >> Share

  72. PENG J, Ran Y, Xie H, Deng L, et al
    Sarco/Endoplasmic Reticulum Ca(2+) Transporting ATPase (SERCA) Modulates Autophagic, Inflammatory, and Mitochondrial Responses during Influenza A Virus Infection in Human Lung Cells.
    J Virol. 2021 Mar 10. pii: JVI.00217-21. doi: 10.1128/JVI.00217.
    >> Share

  73. GONG W, He X, Huang K, Zhang Y, et al
    Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
    J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
    >> Share

  74. PHAN T, Fay EJ, Lee Z, Aron S, et al
    Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
    >> Share

  75. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    >> Share

    February 2021
  76. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    Correction for Jeong et al., "In Vitro Profiling of Laninamivir-Resistant Substitutions in N3 to N9 Avian Influenza Virus Neuraminidase Subtypes and Their Association with In Vivo Susceptibility".
    J Virol. 2021;95.
    >> Share

  77. YANG F, Pang B, Lai KK, Cheung NN, et al
    Discovery of a novel specific inhibitor targeting influenza A nucleoprotein with pleiotropic inhibitory effects on various steps of viral life cycle.
    J Virol. 2021 Feb 24. pii: JVI.01432-20. doi: 10.1128/JVI.01432.
    >> Share

  78. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  79. HOYE BJ, Donato CM, Lisovski S, Deng YM, et al
    Reassortment and persistence of influenza A viruses from diverse geographic origins within Australian wild birds: evidence from a small, isolated population of Ruddy turnstones.
    J Virol. 2021 Feb 24. pii: JVI.02193-20. doi: 10.1128/JVI.02193.
    >> Share

  80. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    >> Share

  81. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    >> Share

  82. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    GPCR and ion channel genes used by influenza virus for replication.
    J Virol. 2021 Feb 3. pii: JVI.02410-20. doi: 10.1128/JVI.02410.
    >> Share

    January 2021
  83. LEVENE RE, Shrestha SD, Gaglia MM
    The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.
    J Virol. 2021 Jan 27. pii: JVI.02312-20. doi: 10.1128/JVI.02312.
    >> Share

  84. ZHANG X, Pu J, Sun Y, Yuhai B, et al
    Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.
    J Virol. 2021 Jan 6. pii: JVI.01272-20. doi: 10.1128/JVI.01272.
    >> Share

  85. PATIL A, Anhlan D, Ferrando V, Mecate-Zambrano A, et al
    Phosphorylation of influenza A virus NS1 at serine 205 mediates its viral polymerase-enhancing function.
    J Virol. 2021 Jan 6. pii: JVI.02369-20. doi: 10.1128/JVI.02369.
    >> Share

  86. FENG M, Zhang Q, Wu W, Chen L, et al
    Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways.
    J Virol. 2021 Jan 6. pii: JVI.02038-20. doi: 10.1128/JVI.02038.
    >> Share

  87. OHTA K, Saka N, Nishio M
    Human parainfluenza virus type 2 V protein modulates iron homeostasis.
    J Virol. 2021 Jan 6. pii: JVI.01861-20. doi: 10.1128/JVI.01861.
    >> Share

    December 2020
  88. WANG Q, Pan W, Wang S, Pan C, et al
    Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
    J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
    >> Share

  89. VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
    Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
    J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
    >> Share

  90. HUMAN S, Hotard AL, Rostad CA, Lee S, et al
    A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol. 2020;95.
    >> Share

  91. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    >> Share

  92. YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
    Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.
    J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
    >> Share

  93. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
    >> Share

  94. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    >> Share

  95. PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
    Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
    J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
    >> Share

    November 2020
  96. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    >> Share

  97. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    >> Share

  98. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    >> Share

  99. MA N, Li X, Jiang H, Dai Y, et al
    Influenza neuraminidase engages CD83 and promotes pulmonary injury.
    J Virol. 2020 Nov 11. pii: JVI.01753-20. doi: 10.1128/JVI.01753.
    >> Share

  100. BAO D, Xue R, Zhang M, Lu C, et al
    N-linked glycosylation plays an important role in budding of NA protein and virulence of influenza viruses.
    J Virol. 2020 Nov 11. pii: JVI.02042-20. doi: 10.1128/JVI.02042.
    >> Share

  101. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    >> Share

  102. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    >> Share

  103. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    >> Share

    October 2020
  104. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  105. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    >> Share

  106. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    >> Share

  107. COOK PW, Stark T, Jones J, Kondor R, et al
    Detection and Characterization of Swine-origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans Following Zoonotic Transmission.
    J Virol. 2020 Oct 28. pii: JVI.01066-20. doi: 10.1128/JVI.01066.
    >> Share

  108. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    >> Share

  109. JOBE F, Simpson J, Hawes P, Guzman E, et al
    Respiratory Syncytial Virus Sequesters NF-kappaB Subunit p65 to Cytoplasmic Inclusion Bodies To Inhibit Innate Immune Signaling.
    J Virol. 2020;94.
    >> Share

  110. GAO Q, Yang C, Ren C, Zhang S, et al
    Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
    J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
    >> Share

  111. MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
    A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
    J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
    >> Share

  112. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    >> Share

  113. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    >> Share

  114. LI Z, Qu X, Liu X, Huan C, et al
    GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    >> Share

  115. ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
    PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
    J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
    >> Share

  116. WEI Y, Zeng Y, Zhang X, Xu S, et al
    The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
    J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
    >> Share

    September 2020
  117. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    >> Share

  118. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    >> Share

  119. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    >> Share

  120. KINDER JT, Moncman CL, Barrett C, Jin H, et al
    Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    J Virol. 2020;94.
    >> Share

  121. MELIOPOULOS V, Cherry S, Wohlgemuth N, Honce R, et al
    Primary swine respiratory epithelial cell lines for the efficient isolation and propagation of influenza A viruses.
    J Virol. 2020 Sep 23. pii: JVI.01091-20. doi: 10.1128/JVI.01091.
    >> Share

  122. ZHANG X, Cunningham FL, Li L, Hanson-Dorr K, et al
    Tissue tropisms of avian influenza A viruses affect their spillovers from wild birds to pigs.
    J Virol. 2020 Sep 23. pii: JVI.00847-20. doi: 10.1128/JVI.00847.
    >> Share

  123. STEINER F, Pavlovic J
    Subcellular localization of MxB determines its antiviral potential against influenza A virus.
    J Virol. 2020 Sep 9. pii: JVI.00125-20. doi: 10.1128/JVI.00125.
    >> Share

  124. SONG J, Sun H, Sun H, Jiang Z, et al
    Swine microRNAs ssc-miR-221-3p and ssc-miR-222 restrict the cross-species infection of avian influenza virus.
    J Virol. 2020 Sep 9. pii: JVI.01700-20. doi: 10.1128/JVI.01700.
    >> Share

  125. EL-SHESHENY R, Franks J, Turner J, Seiler P, et al
    Continued Evolution of H5Nx Avian Influenza Viruses in Bangladeshi Live Poultry Markets: Pathogenic Potential in Poultry and Mammalian Models.
    J Virol. 2020 Sep 9. pii: JVI.01141-20. doi: 10.1128/JVI.01141.
    >> Share

  126. KIRKPATRICK E, Henry C, McMahon M, Jiang K, et al
    Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity.
    J Virol. 2020 Sep 9. pii: JVI.01185-20. doi: 10.1128/JVI.01185.
    >> Share

  127. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    >> Share

  128. CHIA BS, Li B, Cui A, Eisenhaure T, et al
    Loss of the nuclear protein RTF2 enhances influenza replication.
    J Virol. 2020 Sep 2. pii: JVI.00319-20. doi: 10.1128/JVI.00319.
    >> Share

    August 2020
  129. BUSSE DC, Habgood-Coote D, Clare S, Brandt C, et al
    Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    >> Share

  130. GAO R, Sreenivasan CC, Sheng Z, Hause BM, et al
    Human Monoclonal Antibody Derived from Transchromosomic (Tc) Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the HA Head Domain.
    J Virol. 2020 Aug 26. pii: JVI.00945-20. doi: 10.1128/JVI.00945.
    >> Share

  131. VIGIL A, Frias-Staheli N, Carabeo T, Wittekind M, et al
    Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Anti-Viral Activities and Enables Broad Coverage Combination Therapies.
    J Virol. 2020 Aug 26. pii: JVI.00052-20. doi: 10.1128/JVI.00052.
    >> Share

  132. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    >> Share

  133. DANIELS RS, Tse H, Ermetal B, Xiang Z, et al
    Molecular characterisation of Influenza C viruses from outbreaks in Hong Kong SAR, China.
    J Virol. 2020 Aug 19. pii: JVI.01051-20. doi: 10.1128/JVI.01051.
    >> Share

  134. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    >> Share

  135. WANG Y, Lv Y, Niu X, Dong J, et al
    L226Q mutation on influenza H7N9 virus hemagglutinin increases receptor-binding avidity and leads to biased antigenicity evaluation.
    J Virol. 2020 Aug 12. pii: JVI.00667-20. doi: 10.1128/JVI.00667.
    >> Share

  136. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

    July 2020
  137. KAPLAN BS, Kimble JB, Chang J, Anderson TK, et al
    Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.
    J Virol. 2020;94.
    >> Share

  138. CLEMENTS AL, Sealy JE, Peacock TP, Sadeyen JR, et al
    Contribution of segment 3 to the acquisition of virulence in contemporary H9N2 avian influenza viruses.
    J Virol. 2020 Jul 29. pii: JVI.01173-20. doi: 10.1128/JVI.01173.
    >> Share

  139. OSTBYE H, Gao J, Rakic Martinez M, Wang H, et al
    N-linked glycan sites on the influenza NA head domain are required for efficient IAV incorporation and replication.
    J Virol. 2020 Jul 22. pii: JVI.00874-20. doi: 10.1128/JVI.00874.
    >> Share

  140. CHANG P, Sealy JE, Sadeyen JR, Bhat S, et al
    Immune escape adaptive mutations in the H7N9 avian influenza hemagglutinin protein increase virus replication fitness and decrease pandemic potential.
    J Virol. 2020 Jul 22. pii: JVI.00216-20. doi: 10.1128/JVI.00216.
    >> Share

  141. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    >> Share

  142. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    >> Share

  143. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    >> Share

  144. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    >> Share

  145. ARAI Y, Elgendy EM, Daidoji T, Ibrahim MS, et al
    H9N2 influenza virus infections in human cells require a balance between NA sialidase activity and HA receptor affinity.
    J Virol. 2020 Jul 8. pii: JVI.01210-20. doi: 10.1128/JVI.01210.
    >> Share

  146. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    >> Share

  147. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    >> Share

  148. BELSER JA, Sun X, Brock N, Pappas C, et al
    Genetically and antigenically divergent influenza A(H9N2) viruses exhibit differential replication and transmission phenotypes in mammalian models.
    J Virol. 2020 Jul 1. pii: JVI.00451-20. doi: 10.1128/JVI.00451.
    >> Share

  149. WAN XF, Ferguson L, Oliva J, Rubrum A, et al
    Limited cross-protection provided by prior infection contributes to high prevalence of influenza D viruses in cattle.
    J Virol. 2020 Jul 1. pii: JVI.00240-20. doi: 10.1128/JVI.00240.
    >> Share

    June 2020
  150. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    >> Share

  151. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    >> Share

  152. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    >> Share

  153. XU C, Xu B, Wu Y, Yang S, et al
    Erratum for Xu et al., "A Single Amino Acid at Position 431 of the PB2 Protein Determines the Virulence of H1N1 Swine Influenza Viruses in Mice".
    J Virol. 2020;94.
    >> Share

  154. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    >> Share

  155. GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
    Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
    J Virol. 2020;94.
    >> Share

  156. DENG Y, Herbert JA, Robinson E, Ren L, et al
    Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    J Virol. 2020;94.
    >> Share

  157. ZHENG A, Sun W, Xiong X, Freyn AW, et al
    Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    J Virol. 2020 Jun 3. pii: JVI.00742-20. doi: 10.1128/JVI.00742.
    >> Share

    May 2020
  158. LIU L, Song S, Shen Y, Ma C, et al
    Truncation of PA-X contributes to virulence and transmission of H3N8 and H3N2 canine influenza viruses in dogs.
    J Virol. 2020 May 27. pii: JVI.00949-20. doi: 10.1128/JVI.00949.
    >> Share

  159. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    >> Share

  160. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    >> Share

  161. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    >> Share

  162. LI J, Li M, Wang X, Sun M, et al
    Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    J Virol. 2020;94.
    >> Share

  163. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    >> Share

    April 2020
  164. MINE J, Uchida Y, Takemae N, Saito T, et al
    Genetic characterization of influenza A viruses in Japanese swine during 2015-2019.
    J Virol. 2020 Apr 29. pii: JVI.02169-19. doi: 10.1128/JVI.02169.
    >> Share

  165. EGGINK D, Spronken M, van der Woude R, Buzink J, et al
    Phenotypic effects of substitutions within the receptor binding site of highly pathogenic avian influenza H5N1 observed during human infection.
    J Virol. 2020 Apr 22. pii: JVI.00195-20. doi: 10.1128/JVI.00195.
    >> Share

  166. VERHAGEN JH, Poen M, Stallknecht DE, van der Vliet S, et al
    Phylogeography and antigenic diversity of low pathogenic avian influenza H13 and H16 viruses.
    J Virol. 2020 Apr 22. pii: JVI.00537-20. doi: 10.1128/JVI.00537.
    >> Share

  167. RAHIM MMA, Parsons BD, Price EL, Slaine PD, et al
    Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins.
    J Virol. 2020 Apr 22. pii: JVI.00165-20. doi: 10.1128/JVI.00165.
    >> Share

  168. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    >> Share

  169. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    >> Share

  170. KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
    Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    J Virol. 2020;94.
    >> Share

  171. WIGNALL-FLEMING EB, Vasou A, Young D, Short JAL, et al
    Innate intracellular antiviral responses restrict the amplification of defective virus genomes of Parainfluenza Virus type 5.
    J Virol. 2020 Apr 15. pii: JVI.00246-20. doi: 10.1128/JVI.00246.
    >> Share

  172. WALKER AP, Sharps J, Fodor E
    Mutation of an influenza virus polymerase 3' RNA promoter binding site inhibits transcription elongation.
    J Virol. 2020 Apr 15. pii: JVI.00498-20. doi: 10.1128/JVI.00498.
    >> Share

  173. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    >> Share

  174. PEACOCK TP, Swann OC, Salvesen HA, Staller E, et al
    Swine ANP32A supports avian influenza virus polymerase.
    J Virol. 2020 Apr 8. pii: JVI.00132-20. doi: 10.1128/JVI.00132.
    >> Share

  175. OKUYA K, Yoshida R, Manzoor R, Saito S, et al
    A potential role of non-neutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes.
    J Virol. 2020 Apr 8. pii: JVI.00408-20. doi: 10.1128/JVI.00408.
    >> Share

  176. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    >> Share

  177. VIGEVENO RM, Poen MJ, Parker E, Holwerda M, et al
    Outbreak severity of highly pathogenic avian influenza A(H5N8) viruses is inversely correlated to polymerase complex activity and interferon induction.
    J Virol. 2020 Apr 1. pii: JVI.00375-20. doi: 10.1128/JVI.00375.
    >> Share

  178. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    >> Share

  179. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    >> Share

    March 2020
  180. DISKIN ER, Friedman K, Krauss S, Nolting JM, et al
    Subtype diversity of influenza A virus in North American waterfowl: a multi-decade study.
    J Virol. 2020 Mar 18. pii: JVI.02022-19. doi: 10.1128/JVI.02022.
    >> Share

  181. CLOHISEY S, Parkinson N, Wang B, Bertin N, et al
    Comprehensive characterisation of transcriptional activity during influenza A virus infection reveals biases in cap-snatching of host RNA sequences.
    J Virol. 2020 Mar 11. pii: JVI.01720-19. doi: 10.1128/JVI.01720.
    >> Share

  182. SUN Y, Hu Z, Zhang X, Chen M, et al
    R195K mutation in the PA-X protein increases the virulence and transmission of influenza A virus in mammalian hosts.
    J Virol. 2020 Mar 11. pii: JVI.01817-19. doi: 10.1128/JVI.01817.
    >> Share

    February 2020
  183. WANG B, Saito Y, Nishimura M, Ren Z, et al
    An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.
    J Virol. 2020;94.
    >> Share

  184. FIGUEROA T, Bessiere P, Coggon A, Bouwman KM, et al
    THE MICROBIOTA CONTRIBUTES TO THE CONTROL OF HIGHLY PATHOGENIC H5N9 INFLUENZA VIRUS REPLICATION IN DUCKS.
    J Virol. 2020 Feb 26. pii: JVI.00289-20. doi: 10.1128/JVI.00289.
    >> Share

  185. ISHIDA H, Murakami S, Kamiki H, Matsugo H, et al
    Establishment of a Reverse Genetics System for Influenza D Virus.
    J Virol. 2020 Feb 26. pii: JVI.01767-19. doi: 10.1128/JVI.01767.
    >> Share

  186. FORBESTER JL, Clement M, Wellington D, Yeung A, et al
    IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived myeloid cells and murine models.
    J Virol. 2020 Feb 19. pii: JVI.00121-20. doi: 10.1128/JVI.00121.
    >> Share

  187. CASTRO IA, Jorge DMM, Ferreri LM, Martins RB, et al
    Silent infection of B and CD8(+)T lymphocytes by influenza A virus in children with tonsillar hypertrophy.
    J Virol. 2020 Feb 19. pii: JVI.01969-19. doi: 10.1128/JVI.01969.
    >> Share

  188. BARNARD KN, Alford-Lawrence BK, Buchholz DW, Wasik BR, et al
    Modified sialic acids on mucus and erythrocytes inhibit influenza A HA and NA functions.
    J Virol. 2020 Feb 12. pii: JVI.01567-19. doi: 10.1128/JVI.01567.
    >> Share

  189. BALACHANDRAN S, Rall GF
    The Benefits and Perils of Necroptosis in Influenza Infection.
    J Virol. 2020 Feb 12. pii: JVI.01101-19. doi: 10.1128/JVI.01101.
    >> Share

    January 2020
  190. XU C, Xu B, Wu Y, Yang S, et al
    A single amino acid at position 431 of the PB2 protein determines the virulence of H1N1 swine influenza viruses in mice.
    J Virol. 2020 Jan 29. pii: JVI.01930-19. doi: 10.1128/JVI.01930.
    >> Share

  191. SKARLUPKA AL, Reneer ZB, Abreu RB, Ross TM, et al
    An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses.
    J Virol. 2020 Jan 29. pii: JVI.02061-19. doi: 10.1128/JVI.02061.
    >> Share

  192. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    >> Share

  193. BEERENS N, Heutink R, Harders F, Bossers A, et al
    Emergence and selection of a highly pathogenic avian influenza H7N3 virus.
    J Virol. 2020 Jan 22. pii: JVI.01818-19. doi: 10.1128/JVI.01818.
    >> Share

  194. WONG SS, Waite B, Ralston J, Wood T, et al
    Hemagglutinin and neuraminidase antibodies are induced in an age- and subtype- dependent manner after influenza virus infection.
    J Virol. 2020 Jan 15. pii: JVI.01385-19. doi: 10.1128/JVI.01385.
    >> Share

  195. PARK JG, Avila-Perez G, Nogales A, Blanco-Lobo P, et al
    Identification and characterization of novel compounds with broad spectrum antiviral activity against influenza A and B viruses.
    J Virol. 2020 Jan 15. pii: JVI.02149-19. doi: 10.1128/JVI.02149.
    >> Share

  196. XIA C, Wolf JJ, Sun C, Xu M, et al
    PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor.
    J Virol. 2020 Jan 8. pii: JVI.01572-19. doi: 10.1128/JVI.01572.
    >> Share

  197. LE NOUEN C, Luongo CL, Yang L, Mueller S, et al
    Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity.
    J Virol. 2020;94.
    >> Share

  198. AGGARWAL M, Leser GP, Lamb RA
    Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses.
    J Virol. 2020 Jan 2. pii: JVI.01888-19. doi: 10.1128/JVI.01888.
    >> Share

    December 2019
  199. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
    J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
    >> Share

  200. QIU Y, Stegalkina S, Zhang J, Boudanova E, et al
    Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    J Virol. 2019 Dec 11. pii: JVI.01035-19. doi: 10.1128/JVI.01035.
    >> Share

  201. PARSONS L, An Y, Qi L, White M, et al
    Influenza Hemagglutinins H2, H5, H6, and H11 are not Targets of Pulmonary Surfactant Protein D: N-glycan subtypes in host-pathogen interactions.
    J Virol. 2019 Dec 11. pii: JVI.01951-19. doi: 10.1128/JVI.01951.
    >> Share

  202. VALESANO AL, Fitzsimmons WJ, McCrone JT, Petrie JG, et al
    Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts.
    J Virol. 2019 Dec 4. pii: JVI.01710-19. doi: 10.1128/JVI.01710.
    >> Share

  203. ZHONG G, Fan S, Hatta M, Nakatsu S, et al
    Mutations in the NA-like protein of bat influenza H18N11 virus enhance virus replication in mammalian cells, mice, and ferrets.
    J Virol. 2019 Dec 4. pii: JVI.01416-19. doi: 10.1128/JVI.01416.
    >> Share

    November 2019
  204. OLIVA J, Mettier J, Sedano L, Delverdier M, et al
    A murine model for the study of influenza D virus.
    J Virol. 2019 Nov 27. pii: JVI.01662-19. doi: 10.1128/JVI.01662.
    >> Share

  205. KARAKUS U, Pohl MO, Stertz S
    Breaking the convention: Sialoglycan variants, Co-receptors and Alternative Receptors for Influenza A Virus Entry.
    J Virol. 2019 Nov 27. pii: JVI.01357-19. doi: 10.1128/JVI.01357.
    >> Share

  206. RODRIGUEZ-FRANDSEN A, Martin-Sancho L, Gounder AP, Chang MW, et al
    Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells.
    J Virol. 2019 Nov 27. pii: JVI.01410-19. doi: 10.1128/JVI.01410.
    >> Share

  207. SMITH A, Rodriguez L, Ghouayel ME, Nogales A, et al
    A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.
    J Virol. 2019 Nov 20. pii: JVI.01065-19. doi: 10.1128/JVI.01065.
    >> Share

  208. RIJAL P, Wang BB, Tan TK, Schimanski L, et al
    Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
    J Virol. 2019 Nov 20. pii: JVI.01182-19. doi: 10.1128/JVI.01182.
    >> Share

  209. MISTRY B, Long JS, Schreyer J, Staller E, et al
    Elucidating the interactions between influenza virus polymerase and host factor ANP32A.
    J Virol. 2019 Nov 6. pii: JVI.01353-19. doi: 10.1128/JVI.01353.
    >> Share

  210. WANG G, Jiang L, Wang J, Zhang J, et al
    The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry.
    J Virol. 2019 Nov 6. pii: JVI.01707-19. doi: 10.1128/JVI.01707.
    >> Share

  211. RUSSIER M, Yang G, Briard B, Meliopoulos V, et al
    HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.
    J Virol. 2019 Nov 6. pii: JVI.01423-19. doi: 10.1128/JVI.01423.
    >> Share

  212. HU B, Siche S, Moller L, Veit M, et al
    Amphipathic helices of cellular proteins can replace the helix in M2 of Influenza A virus with only small effects on virus replication.
    J Virol. 2019 Nov 6. pii: JVI.01605-19. doi: 10.1128/JVI.01605.
    >> Share

    October 2019
  213. KONG H, Ma S, Wang J, Gu C, et al
    Identification of key amino acids in the PB2 and M1 proteins of H7N9 influenza virus that affect its transmission in guinea pigs.
    J Virol. 2019 Oct 9. pii: JVI.01180-19. doi: 10.1128/JVI.01180.
    >> Share

  214. MONTEAGUDO PL, Munoz-Moreno R, Fribourg M, Potla U, et al
    Differential modulation of innate immune responses in human primary cells by influenza A viruses carrying human or avian non-structural 1 proteins.
    J Virol. 2019 Oct 9. pii: JVI.00999-19. doi: 10.1128/JVI.00999.
    >> Share

  215. HENSEN L, Matrosovich T, Roth K, Klenk HD, et al
    Hemagglutinin-dependent tropism of H5N1 and H7N9 influenza viruses to human endothelial cells is determined by reduced stability of the HA which allows the virus to cope with inefficient endosomal acidification and constitutively expressed IFITM3.
    J Virol. 2019 Oct 9. pii: JVI.01223-19. doi: 10.1128/JVI.01223.
    >> Share

  216. LAPORTE M, Stevaert A, Raeymaekers V, Boogaerts T, et al
    Hemagglutinin cleavability, acid-stability and temperature dependence optimize influenza B virus for replication in human airways.
    J Virol. 2019 Oct 9. pii: JVI.01430-19. doi: 10.1128/JVI.01430.
    >> Share

    September 2019
  217. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    >> Share

    May 2019
  218. HUANG S, Zhu B, Cheon IS, Goplen NP, et al
    PPAR-gamma in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    J Virol. 2019;93.
    >> Share

  219. MCGINNES CULLEN L, Schmidt MR, Morrison TG
    Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    J Virol. 2019;93.
    >> Share

    February 2019
  220. JORQUERA PA, Mathew C, Pickens J, Williams C, et al
    Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro.
    J Virol. 2019;93.
    >> Share

    January 2019
  221. MANLEY GCA, Stokes CA, Marsh EK, Sabroe I, et al
    DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1beta Signaling.
    J Virol. 2019;93.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016